Synthetic Biologics Reports Third Quarter 2013 Financial Results and Operational Update

— Conference Call Today, November 14, at 10 a.m. Eastern Time — ROCKVILLE, Md., Nov. 14, 2013 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, today reported financial results for the three and nine months ended September 30, 2013 and provided an […]

Synthetic Biologics Reports Third Quarter 2013 Financial Results and Operational Update Read More »